We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

616 hedge funds and large institutions have $1.57B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 616 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

497% more call options, than puts

Call options by funds: $48M | Put options by funds: $8.03M

Holders
616
Holders Change
+616
Holders Change %
–
% of All Funds
12.14%
Holding in Top 10
8
Holding in Top 10 Change
+8
Holding in Top 10 Change %
% of All Funds
0.16%
New
616
Increased
–
Reduced
–
Closed
–
Calls
$48M
Puts
$8.03M
Net Calls
+$39.9M
Net Calls Change
+$39.9M

Top Buyers

Rank Fund Capital Flow
1
LCM
Laurion Capital Management
New York
+$130M
2
PCM
Pentwater Capital Management
Florida
+$92.5M
3
FCM
Farallon Capital Management
California
+$79M
4
Viking Global Investors
Viking Global Investors
Connecticut
+$67.6M
5
ACM
Abrams Capital Management
Massachusetts
+$60.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LS
576
Leelyn Smith
Illinois
$11 +$9.14K +3,514 New
PCFFS
577
Pacific Center for Financial Services
California
– +$13 +5 New
RFM
578
Royal Fund Management
Florida
– +$23 +9 New
LWA
579
Lowe Wealth Advisors
Maryland
– +$39 +15 New
CA
580
Crewe Advisors
Utah
– +$42 +16 New
APC
581
Aspire Private Capital
North Carolina
– +$47 +18 New
SA
582
SRH Advisors
Kansas
– +$52 +20 New
SIAS
583
Shine Investment Advisory Services
Colorado
– +$65 +25 New
1NWS
584
1 North Wealth Services
Maryland
– +$86 +33 New
WWM
585
Willingdon Wealth Management
North Carolina
– +$94 +36 New
RWB
586
RMR Wealth Builders
New Jersey
– +$96 +37 New
IFAM
587
Institutional & Family Asset Management
Colorado
– +$101 +39 New
PWP
588
Personal Wealth Partners
Minnesota
– +$101 +39 New
DAM
589
Delta Asset Management
Tennessee
– +$117 +45 New
LFG
590
LifePlan Financial Group
Ohio
– +$125 +48 New
LWM
591
Lenox Wealth Management
Ohio
– +$127 +49 New
SFA
592
Semmax Financial Advisors
North Carolina
– +$127 +49 New
BHWM
593
Bay Harbor Wealth Management
Maryland
– +$130 +50 New
FEG
594
Financial Enhancement Group
Indiana
– +$130 +50 New
ST
595
Sageworth Trust
Pennsylvania
– +$130 +50 New
TCWM
596
Total Clarity Wealth Management
Illinois
– +$138 +53 New
CFFP
597
Center for Financial Planning
Michigan
– +$140 +54 New
TIM
598
Tortoise Investment Management
New York
– +$143 +55 New
CAM
599
ClariVest Asset Management
California
– +$161 +62 New
TPWA
600
TRUE Private Wealth Advisors
Oregon
– +$161 +62 New
21 22 23
24
25

BMY.RT Hedge Fund Activity: Q4 2019 in Review

616 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q4 2019, worth a combined $1.57B.

Buyers outnumbered sellers: 616 funds opened new BMY.RT positions and 0 closed out — a net gain of 616 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Laurion Capital Management, opening a new position worth an estimated $130M.

  • 616 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $1.57B of Bristol-Myers Squibb Company Contingent Value Rights stock for Q4 2019.
  • 616 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q4 2019 and 0 closed out, a net change of +616 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q4 2019 was Laurion Capital Management, an estimated $130M added.

Based on aggregated 13F filings for Q4 2019.